Table 1 Patient characteristics, tumor classification and treatment of all patients with recurrent head and neck cancer
Pat | ReRT | Age (y) | KPS (%) | Localization | Type | Concept | T | N | M | R | G | Interval (y) | ReRT EQD2 (Gy) | Cum. EQD2 (Gy) | CTV (ccm) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
01 | CIRT | 54 | 70 | Oral cavity | SCC | Postop | 4 | 0 | 0 | 2 | 2 | 1.0 | 75.0 | 129.0 | 167.9 |
02 | CIRT | 57 | 90 | Nasopharynx | SCC | Def | 2 | 0 | 0 | 2 | 0.7 | 63.8 | 137.8 | 30.6 | |
03 | CIRT | 61 | 90 | Hypopharynx | SCC | Def | 4 | 0 | 0 | 3 | 3.6 | 63.8 | 123.8 | 84.0 | |
04 | VMAT | 72 | 80 | Sinuses | SCC | Def | 4 | 0 | 0 | 2 | 1.0 | 60.0 | 126.0 | 110.0 | |
05 | CIRT | 73 | 70 | Oral cavity | MEC | Def | 4 | 0 | 0 | 3 | 1.0 | 67.5 | 147.5 | 25.0 | |
06 | VMAT | 71 | 80 | Oropharynx | SCC | Def | 4 | 0 | 0 | 2 | 7.2 | 60.0 | 123.0 | 65.0 | |
07 | VMAT | 54 | 80 | Nasopharynx | SCC | Def | 1 | 2 | 0 | 3 | 4.5 | 60.0 | 124.0 | 54.7 | |
08 | CIRT | 54 | 90 | Sinuses | AC | Postop | 3 | 0 | 0 | 2 | 3 | 1.6 | 67.5 | 127.5 | 49.3 |
09 | VMAT | 52 | 80 | Skull base | AC | def | 4 | 0 | 0 | 3 | 0.9 | 60.0 | 130.0 | 10.4 | |
10 | VMAT | 49 | 80 | Nasopharynx | SCC | def | 4 | 0 | 0 | 3 | 3.3 | 60.0 | 124.0 | 31.7 | |
11 | VMAT | 65 | 80 | Nasal cavity | SCC | Def | 3 | 0 | 0 | 3 | 4.0 | 60.0 | 130.0 | 37.4 | |
12 | VMAT | 55 | 80 | Nasal cavity | SCC | Postop | 3 | 0 | 1 | 1 | 2 | 1.7 | 60.0 | 120.0 | 25.6 |
13 | CIRT | 62 | 70 | Oral cavity | SCC | Def | 3 | 0 | 0 | 2 | 8.3 | 63.8 | 137.8 | 42.4 | |
14 | CIRT | 69 | 70 | Oral cavity | SCC | Def | 4 | 0 | 0 | 3 | 28.0 | 63.8 | 138.8 | 196.4 | |
15 | CIRT | 50 | 90 | Nasal cavity | SCC | Postop | 4 | 0 | 0 | 2 | 3 | 1.2 | 63.8 | 129.8 | 139.6 |
16 | CIRT | 69 | 80 | Oropharynx | SCC | Def | 4 | 0 | 0 | 3 | 17.9 | 67.5 | 133.5 | 42.6 |